Avantor, Inc. $AVTR Shares Purchased by Sivik Global Healthcare LLC

Sivik Global Healthcare LLC boosted its holdings in Avantor, Inc. (NYSE:AVTR) by 12.5% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 225,000 shares of the company’s stock after acquiring an additional 25,000 shares during the quarter. Sivik Global Healthcare LLC’s holdings in Avantor were worth $3,029,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of AVTR. 1832 Asset Management L.P. raised its position in Avantor by 89.8% in the first quarter. 1832 Asset Management L.P. now owns 18,127,204 shares of the company’s stock worth $293,842,000 after acquiring an additional 8,578,493 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in Avantor by 53.2% in the first quarter. The Manufacturers Life Insurance Company now owns 14,034,699 shares of the company’s stock worth $227,502,000 after acquiring an additional 4,876,524 shares in the last quarter. Invesco Ltd. raised its position in Avantor by 19.3% in the first quarter. Invesco Ltd. now owns 11,669,411 shares of the company’s stock worth $189,161,000 after acquiring an additional 1,884,273 shares in the last quarter. KBC Group NV raised its position in Avantor by 483.7% in the first quarter. KBC Group NV now owns 1,823,686 shares of the company’s stock worth $29,562,000 after acquiring an additional 1,511,255 shares in the last quarter. Finally, Clarkston Capital Partners LLC raised its position in Avantor by 17.8% in the first quarter. Clarkston Capital Partners LLC now owns 9,591,950 shares of the company’s stock worth $155,486,000 after acquiring an additional 1,446,125 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on AVTR shares. Barclays increased their price objective on Avantor from $13.00 to $15.00 and gave the stock an “overweight” rating in a research report on Thursday, October 2nd. Stifel Nicolaus set a $12.00 price target on Avantor and gave the company a “hold” rating in a research report on Monday, August 4th. Robert W. Baird dropped their price target on Avantor from $18.00 to $15.00 and set an “outperform” rating for the company in a research report on Monday, August 4th. Royal Bank Of Canada dropped their price target on Avantor from $20.00 to $17.00 and set an “outperform” rating for the company in a research report on Monday, August 4th. Finally, Evercore ISI dropped their price target on Avantor from $18.00 to $16.00 and set an “outperform” rating for the company in a research report on Monday, August 4th. Seven research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, Avantor presently has an average rating of “Hold” and a consensus target price of $15.65.

Insider Buying and Selling

In related news, CAO Steven W. Eck sold 3,476 shares of Avantor stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total transaction of $39,591.64. Following the completion of the sale, the chief accounting officer owned 55,068 shares in the company, valued at approximately $627,224.52. This trade represents a 5.94% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.20% of the company’s stock.

Avantor Trading Down 1.0%

Shares of AVTR stock opened at $13.41 on Friday. The stock has a market cap of $9.14 billion, a P/E ratio of 13.54, a P/E/G ratio of 4.36 and a beta of 0.98. The business has a fifty day simple moving average of $12.79 and a 200-day simple moving average of $13.41. Avantor, Inc. has a fifty-two week low of $10.82 and a fifty-two week high of $26.14. The company has a quick ratio of 0.67, a current ratio of 0.98 and a debt-to-equity ratio of 0.48.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.24 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). The company had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Avantor had a return on equity of 11.39% and a net margin of 10.31%.The company’s revenue for the quarter was down 1.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.25 EPS. On average, analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.